Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Zuowei Zhao"'
Publikováno v:
Translational Oncology, Vol 46, Iss , Pp 102010- (2024)
Background: STIL is an important cell cycle-regulating protein specifically recruited to the mitotic centrosome to promote the replication of centrioles in dividing cells. However, the potential role of STIL in the regulation of the biological functi
Externí odkaz:
https://doaj.org/article/8ab18dc8e7dc476e8b6f7d24bf100957
Autor:
Le Ma, Pin Gao, Zhenzhen Liu, Dechuang Jiao, Rui Ling, Jingjing Xiao, Yi Zhao, Yitong Wang, Hongjian Yang, Yunjiang Liu, Ke Liu, Jianguo Zhang, Guangyan Li, Dahua Mao, Yinglei Deng, Jianjun He, Maimaitiaili Amina, Zhigang Yu, Wang Fei, Yinhua Liu, Peifen Fu, Minya Yao, Jiandong Wang, Li Zhu, Hongchuan Jiang, Zuowei Zhao, Xingsong Tian, Zhongwei Cao, Xinyu Ma, Kejin Wu, Shaomei Fu, Ailin Song, Yanwei Wang, Jin Feng, Zhimin Fan, Yanjie Yin
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 11, Pp 1369-1371 (2024)
Externí odkaz:
https://doaj.org/article/b90ffbacd0744ca9a054fba37a429d86
Autor:
Amina Maimaitiaili, Yijun Li, Na Chai, Zhenzhen Liu, Rui Ling, Yi Zhao, Hongjian Yang, Yunjiang Liu, Ke Liu, Jianguo Zhang, Dahua Mao, Zhigang Yu, Yinhua Liu, Peifen Fu, Jiandong Wang, Hongchuan Jiang, Zuowei Zhao, Xingsong Tian, Zhongwei Cao, Kejin Wu, Ailin Song, Feng Jin, Puzhao Wu, Jianjun He, Zhimin Fan, Huimin Zhang
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
PurposeThis study aimed to investigate the factors associated with pathologic node-negativity (ypN0) in patients who received neoadjuvant chemotherapy (NAC) to develop and validate an accurate prediction nomogram.MethodsThe CSBrS-012 study (2010–20
Externí odkaz:
https://doaj.org/article/17e01deab2924ff288cda9694e6f3968
Autor:
Xuhui Guo, Jiao Zhang, Xilong Gong, Jia Wang, Hao Dai, Dechuang Jiao, Rui Ling, Yi Zhao, Hongjian Yang, Yunjiang Liu, Ke Liu, Jianguo Zhang, Dahua Mao, Jianjun He, Zhigang Yu, Yinhua Liu, Peifen Fu, Jiandong Wang, Hongchuan Jiang, Zuowei Zhao, Xingsong Tian, Zhongwei Cao, Kejin Wu, Ailin Song, Feng Jin, Zhimin Fan, Zhenzhen Liu
Publikováno v:
Breast, Vol 73, Iss , Pp 103671- (2024)
Aim:This study aims to identify suitable candidates for axillary sentinel lymph node biopsy (SLNB) or targeted axillary dissection (TAD) among clinical N2 (cN2) triple-negative (TN) or HER2 positive (HER2+)breast cancer patients following neoadjuva
Externí odkaz:
https://doaj.org/article/968d06c413ef470bb7d464d0ced45e3f
Autor:
Ye Hu, Fengxi Chen, Siwen Sun, Lingzhi Xv, Xueqing Wang, Meiling Wang, Shanshan Zhao, Zuowei Zhao, Man Li
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
This study aimed to explore the efficacy and potential mechanisms of rechallenge therapy with microtubule-targeting agents (MTAs) in patients with HER2-low metastatic breast cancer (MBC). We performed a systematic review to investigate the rechalleng
Externí odkaz:
https://doaj.org/article/7e288d93a73a4df0b2de9a54e8aa6ba0
Publikováno v:
Food Science and Human Wellness, Vol 12, Iss 1, Pp 130-139 (2023)
Polysaccharides are the important biologically active components found in the peel of Dioscorea opposita Thunb. (DTTP). The influences of 4 extraction methods, namely hot water extraction (W), acidic extraction (HA), hot-compressed water extraction (
Externí odkaz:
https://doaj.org/article/885216ceeaf1464fa8445cb79d5b9514
Publikováno v:
Breast, Vol 66, Iss , Pp 31-39 (2022)
Introduction: Platinum-based chemotherapy (PBC) remains the mainstay of treatments for triple-negative breast cancer (TNBC). TNBC is a heterogeneous group, the issue of whether BRCA1/2 mutation carriers have a particular sensitivity to platinum agent
Externí odkaz:
https://doaj.org/article/ce5f1e27b5184e19b4d52fa720ab764b
Autor:
Lanxin Zhang, Siwen Sun, Xiaotian Zhao, Jingwen Liu, Yang Xu, Lingzhi Xu, Chen Song, Na Li, Jing Yu, Shanshan Zhao, Peiyao Yu, Fengqi Fang, Jiping Xie, Xuening Ji, Ruoying Yu, Qiuxiang Ou, Zuowei Zhao, Man Li
Publikováno v:
Molecular Oncology, Vol 16, Iss 20, Pp 3689-3702 (2022)
Approximately 30% of breast cancer (BC) patients suffer from disease relapse after definitive treatment. Monitoring BC at baseline and disease progression using comprehensive genomic profiling would facilitate the prediction of prognosis. We retrospe
Externí odkaz:
https://doaj.org/article/d8a35b9fa8fb4c60be1f45ee129fa64e
Autor:
Heyan Chen, Amina Maimaitiaili, Zhenzhen Liu, Rui Ling, Yi Zhao, Hongjian Yang, Yunjiang Liu, Ke Liu, Jianguo Zhang, Dahua Mao, Zhigang Yu, Yinhua Liu, Peifen Fu, Jiandong Wang, Hongchuan Jiang, Zuowei Zhao, Xingsong Tian, Zhongwei Cao, Kejin Wu, Ailin Song, Feng Jin, Jianjun He, Zhimin Fan, Huimin Zhang
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: In the era of targeted therapy, whether patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer are exempted from anthracycline usage in the neoadjuvant setting is controversial. Objectives: Our objective was
Externí odkaz:
https://doaj.org/article/b7a6802673b94648bd19fb003ad379db
Publikováno v:
Mathematical Biosciences and Engineering, Vol 18, Iss 6, Pp 8331-8353 (2021)
Background: Metastasis-Associated in Colon Cancer 1(MACC1) is a validated biomarker for metastasis and is linked to survival. Although extensive experimental evidence indicates an association between MACC1 and diverse cancers, no pan-cancer analyses
Externí odkaz:
https://doaj.org/article/4fd2072c5b2744bc87a561d506433d97